EPO联合氨甲环酸在改善股骨粗隆间骨折围手术期贫血及失血的疗效与安全性分析
DOI:
作者:
作者单位:

南京医科大学附属江宁医院脊柱外科

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金青年(81802198) , 江苏省自然科学(BK20221176),国家自然科学基金项目(面上项目,重点项目,重大项目)


Efficacy and safety of combined treatment with tranexamic acid and erythropoietin during surgery for intertrochanteric fractures
Author:
Affiliation:

Department of Orthopaedic Surgery,The Affiiated Jiangning Hospital of Nanjing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 评价促红细胞生成素(erythropoietin,EPO) +铁剂改善股骨粗隆间骨折围手术期贫血及联合使用氨甲环酸 ( tranexamic acid,TXA )减少围术期失血及输血率的临床疗效及安全性。方法 回顾分析2018-01~2022-01在我院行股骨粗隆间骨折手术治疗的174例患者,根据治疗情况分3组,A组:对照组;B组:术中静脉联合局部应用TXA;C组:在B组的基础上联合应用EPO和铁剂。搜集并比较3组入院时、术前及术后血红蛋白量(Hb)、术中总失血量、显隐性失血量、围手术期输血率及输血量、住院时间以及血栓等并发症发生情况等。结果 所有患者均获得12个月随访,平均12.7个月。C组入院时Hb量和A组及B组无明显差异;C组术前及术后Hb量较A组及B组明显改善;C组总失血量、输血率及输血量均低于A组,差异均有统计学意义(P<0.05)。术后发生下肢深静脉血栓形成三组发生率比较差异无统计学意义( P>0.05 )。结论 EPO+铁剂可有效改善股骨粗隆间骨折围手术期贫血状况;术中静脉及局部应用TXA能有效减少围手术期失血,减少输血率及输血量,缩短住院时间及住院费用,且不增加围手术期血栓等相关并发症的风险,值得临床推广。

    Abstract:

    Purpose: The aim of study was to assesse the effectiveness and safety of combined treatment with TXA and EPO during the surgery for intertrochanteric fractures(IFs). Methods: Patients with IFs underwent closed reduction and internal fixation proximal femoral nail antirotation (PFNA) from January 2018 and January 2022 were enrolled in this study. The patients were randomly divided into 3 groups: control group (Group A), TXA alone group (Group B), TXA combined with EPO group (Group C). TXA dissolved in 100 mL of saline was administered intravenously at a dose of 15mg/kg over 10 minutes before and after surgery. EPO was injected subcutaneously every other day with 10000U/L. Whereas only 100 mL of saline solution was used in Group A. Perioperative total blood loss, obvious blood loss, and hidden blood loss in the there groups were calculated separately. The blood transfusion rate and volume, haemoglobin levels, postoperative drainage, operative time, and hospitalization day were recorded. Surgery-related complications including thromboembolic events, pulmonary embolism, wound hematoma and infection, cardiovascular and cerebrovascular accidents, respiratory infections, and patient mortality were also recorded to assess the safety. Results: A total of 174 patients, including 62 patients in Group A, 57 in Group B, and 55 in Group C, were enrolled in the study. Mean follow-up was at least 12.2 months for three groups. The patients in the three groups showed similar outcomes regarding the number of cases, age, gender, BMI. EPO and iron significantly improved perioperative anemia in patients with IFs(Group C, p<0.05).There was a trend toward decreased transfusion rate and volume in the TXA group (Group B and Group C, p<0.05). The Group C had advantages over the other two groups in early postoperative functional recovery, hidden blood loss, postoperative drainage, postoperative hospitalization time without increasing the risk of thrombosis and other complications(P<0.05). There were no serious complications occurring during our study. In all cases, fractures healed well and no revision surgery was performed for internal fixation failure during the follow-up. Conclusions: Combined treatment with TXA and EPO significantly improved preoperative anemia and reduced perioperative blood loss rate and volume without increasing the rate of complications in elderly patients with IFs underwent surgery of PFNA.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-01-16
  • 最后修改日期:2024-02-20
  • 录用日期:2024-05-22
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明